|
Ethylene dichloride | CAS 107-06-2 | ||
ClCH2CH2Cl | RTECS KI0525000 | ||
Synonyms & Trade Names 1,2-Dichloroethane; Ethylene chloride; Glycol dichloride |
DOT ID & Guide 1184 129 |
Exposure Limits |
NIOSH REL: Ca TWA 1 ppm (4 mg/m3) ST 2 ppm (8 mg/m3) See Appendix A See Appendix C (Chloroethanes) | ||
OSHA PEL�: TWA 50 ppm C 100 ppm 200 ppm [5-minute maximum peak in any 3 hours] | |||
IDLH Ca [50 ppm] | Conversion 1 ppm = 4.05 mg/m3 |
Physical Description Colorless liquid with a pleasant, chloroform-like odor. [Note: Decomposes slowly, becomes acidic & darkens in color.] |
|||
MW: 99.0 |
BP: 182°F |
FRZ: -32°F |
Sol: 0.9% |
VP: 64 mmHg |
IP: 11.05 eV |
|
Sp.Gr: 1.24 |
Fl.P: 56°F |
UEL: 16% |
LEL: 6.2% |
|
Class IB Flammable Liquid: Fl.P. below 73�F and BP at or above 100�F. | |||
Incompatibilities & Reactivities Strong oxidizers & caustics; chemically-active metals such as magnesium or aluminum powder, sodium & potassium; liquid ammonia [Note: Decomposes to vinyl chloride & HCl above 1112°F.] |
Measurement Methods NIOSH 1003; OSHA 3 |
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet (flammable) Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, ingestion, skin absorption, skin and/or eye contact | |
Symptoms Irritation eyes, corneal opacity; central nervous system depression; nausea, vomiting; dermatitis; liver, kidney, cardiovascular system damage; [potential occupational carcinogen] | |
Target Organs
Eyes, skin, kidneys, liver, central nervous system, cardiovascular system Cancer Site [in animals: forestomach, mammary gland & circulatory system cancer] |
See also: INTRODUCTION |